These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 28970075

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Clinical, radiologic and pathologic features of giant cell tumor of bone treated with denosumab].
    Gong LH, Liu WF, Ding Y, Zhang W, Yang YK, Yu F, Wong GQ, Huang XY, Niu XH.
    Zhonghua Bing Li Xue Za Zhi; 2018 Jun 08; 47(6):449-454. PubMed ID: 29886590
    [Abstract] [Full Text] [Related]

  • 3. [Denosumab may be a supplement to the surgical treatment of giant cell tumours of bone].
    Sørensen AL, Hansen RL, Jørgensen PH.
    Ugeskr Laeger; 2016 Sep 05; 178(36):. PubMed ID: 27593237
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Response evaluation of giant-cell tumor of bone treated by denosumab: Histogram and texture analysis of CT images.
    Yi J, Lee YH, Kim SK, Kim SH, Song HT, Shin KH, Suh JS.
    J Orthop Sci; 2018 May 05; 23(3):570-577. PubMed ID: 29429890
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Ⅱ. Success and Limitations of Denosumab for Giant Cell Tumor of Bone].
    Asano N.
    Gan To Kagaku Ryoho; 2021 Mar 05; 48(3):346-350. PubMed ID: 33790155
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Risks and benefits of combining denosumab and surgery in giant cell tumor of bone-a case series.
    Müller DA, Beltrami G, Scoccianti G, Campanacci DA, Franchi A, Capanna R.
    World J Surg Oncol; 2016 Nov 04; 14(1):281. PubMed ID: 27809843
    [Abstract] [Full Text] [Related]

  • 16. Denosumab-treated giant cell tumor of bone. Its histologic spectrum and potential diagnostic pitfalls.
    Roitman PD, Jauk F, Farfalli GL, Albergo JI, Aponte-Tinao LA.
    Hum Pathol; 2017 May 04; 63():89-97. PubMed ID: 28235628
    [Abstract] [Full Text] [Related]

  • 17. Assessment of denosumab treatment effects and imaging response in patients with giant cell tumor of bone.
    Engellau J, Seeger L, Grimer R, Henshaw R, Gelderblom H, Choy E, Chawla S, Reichardt P, O'Neal M, Feng A, Jacobs I, Roberts ZJ, Braun A, Bach BA.
    World J Surg Oncol; 2018 Sep 19; 16(1):191. PubMed ID: 30231890
    [Abstract] [Full Text] [Related]

  • 18. Objective tumor response to denosumab in patients with giant cell tumor of bone: a multicenter phase II trial.
    Ueda T, Morioka H, Nishida Y, Kakunaga S, Tsuchiya H, Matsumoto Y, Asami Y, Inoue T, Yoneda T.
    Ann Oncol; 2015 Oct 19; 26(10):2149-54. PubMed ID: 26205395
    [Abstract] [Full Text] [Related]

  • 19. Recurrent giant cell tumour of the maxillary sinus and pterygoid process treated with denosumab.
    Rosa D, Dias RB, Salvador JC, Borges A.
    BMJ Case Rep; 2018 Sep 08; 2018():. PubMed ID: 30196254
    [Abstract] [Full Text] [Related]

  • 20. [Analysis of the molecular penotypes and histopathological features of giant cell tumor of bone with denosumab treatment].
    Gong LH, Dong RF, Zhang W, Sun XQ, Zhang M, Ding Y.
    Zhonghua Bing Li Xue Za Zhi; 2021 Jan 08; 50(1):60-62. PubMed ID: 33396989
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.